241 related articles for article (PubMed ID: 4194690)
1. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
2. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
3. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
4. Combined L-dopa and amantadine in Parkinsonism.
Pollock M; Jorgensen PB
Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
[No Abstract] [Full Text] [Related]
5. L-dopa in idiopathic parkinsonism.
Calne DB; Stern GM; Spiers AS; Laurence DR
Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
[No Abstract] [Full Text] [Related]
6. Treatment of parkinsonism with levodopa.
Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
[No Abstract] [Full Text] [Related]
7. L-dopa in postencephalitic parkinsonism.
Calne DB; Stern GM; Laurence DR; Sharkey J; Armitage P
Lancet; 1969 Apr; 1(7598):744-6. PubMed ID: 4180215
[No Abstract] [Full Text] [Related]
8. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
9. L-dopa in the treatment of parkinsonism.
Haleem MA
Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
[No Abstract] [Full Text] [Related]
10. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
11. A year's experience of L-DOPA in the treatment of Parkinson's disease.
Guidetti B; Giuffrè R
Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
[No Abstract] [Full Text] [Related]
12. [Long term treatment of a parkinsonism with l-dopa].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
[No Abstract] [Full Text] [Related]
13. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
14. [Advances in the treatment of parkinsonism].
Dowzenko A
Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308
[No Abstract] [Full Text] [Related]
15. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
Parkes JD; Baxter RC; Marsden CD; Rees JE
J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
[TBL] [Abstract][Full Text] [Related]
16. [L-Dopa therapy in Parkinson's disease. A double-blind study].
Worm-Petersen J; Dupont E; Mikkelsen B
Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
[No Abstract] [Full Text] [Related]
17. L-dopa for postencephalitic Parkinsonism.
Krasner N; Cornelius JM
Br Med J; 1970 Nov; 4(5733):496. PubMed ID: 5481239
[No Abstract] [Full Text] [Related]
18. L-dopa and amantadine in the therapy of parkinsonism.
Weeth JB; Shealy CN; Mercier DA
Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
[No Abstract] [Full Text] [Related]
19. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
20. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
